Literature DB >> 11309516

Prevalence of low bone density in women with developmental disabilities.

J S Jaffe1, A M Timell, B I Gulanski.   

Abstract

This study was designed to assess the prevalence and severity of low bone mineral density in an institutionalized population of postmenopausal women (n = 79) with developmental disabilities, using quantitative ultrasound of the calcaneus. The results demonstrate that this population has a significantly lower quantitative ultrasound index (QUI) of the calcaneus compared with a referent population of age-matched control subjects without mental disabilities. We used the QUI T-score threshold of <-2.0 standard deviations (SDs) to define individuals at high risk for osteoporosis, and 82% of the study participants met this criterion. Furthermore, approx 43% of the population had a heel QUI that was more than 2 SDs below that of age-matched control subjects, consistent with a severe degree of demineralization.

Entities:  

Mesh:

Year:  2001        PMID: 11309516     DOI: 10.1385/jcd:4:1:25

Source DB:  PubMed          Journal:  J Clin Densitom        ISSN: 1094-6950            Impact factor:   2.963


  4 in total

1.  Associations between fracture incidence and use of depot medroxyprogesterone acetate and anti-epileptic drugs in women with developmental disabilities.

Authors:  Kathleen C Watson; Martha J Lentz; Kevin C Cain
Journal:  Womens Health Issues       Date:  2006 Nov-Dec

2.  The Relationship Between Adverse Childhood Events, Resiliency and Health Among Children with Autism.

Authors:  Bethany Rigles
Journal:  J Autism Dev Disord       Date:  2017-01

Review 3.  Endocrine and musculoskeletal abnormalities in patients with Down syndrome.

Authors:  Yousra Hawli; Mona Nasrallah; Ghada El-Hajj Fuleihan
Journal:  Nat Rev Endocrinol       Date:  2009-06       Impact factor: 43.330

Review 4.  Primary care for women with intellectual disabilities.

Authors:  Joanne E Wilkinson; Mary C Cerreto
Journal:  J Am Board Fam Med       Date:  2008 May-Jun       Impact factor: 2.657

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.